Brief: Phibro Animal Health Corp And Rejuvenate Bio Announce Agreement To Develop Gene Therapy For Mitral Valve Disease In Canines
22/06/2022 13:20
June 22 (Reuters) - Phibro Animal Health Corp PAHC.O :
* PHIBRO ANIMAL HEALTH CORPORATION AND REJUVENATE BIO
ANNOUNCE
AGREEMENT TO DEVELOP GENE THERAPY FOR MITRAL VALVE DISEASE IN
CANINES
Source text for Eikon: ID:nBw40jFL1a
Further company coverage: PAHC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phibro Animal Health
See all newsPhibro Animal Health Corp reports results for the quarter ended June 30 - Earnings Summary
Phibro Animal Health Q4 results beat estimates on mineral nutrition growth
Phibro Animal Health Q3 sales and profit beat estimates
Phibro Animal Health Q2 revenue beats estimates on vaccine demand
Brief: Phibro Animal Health Q2 Adjusted EBITDA USD 68.1 Million